Already a member?

Sign in.

Need an Account?
Join Us!
Sign Up
Personal Information
Account Settings
Directory Details
Apply For Member Spotlight
Sign Out

Member & Partner News

Have a company news release you'd like to post? Has your organization recently been awarded an accolade or new project? Do you have a big company announcement or new team member?

Send your information to Greg Picken at greg.picken@techalliance.ca and we'll post your news on the TechAlliance website, helping you get the word out.

February 2nd, 2012
The Achievement Centre International is pleased to announce it has signed its first strategic distribution agreement in France with Kalystos to distribute the work of Nicholas Boothman. Mr. Boothman is one of the most successful authors that The Achievement Centre represents.Kalystos will distribute two programs: the 2-day program FullyConnected in Business, and How to Connect in...
January 27th, 2012
Ottawa, Ontario and London, Ontario – January 25, 2012 – Vocantas and Akira Systems jointly announced today that they have entered into a partnership agreement to bring interactive voice response (IVR) scheduling and workflow to healthcare and higher education markets.Together Akira and Vocantas have formed a new solution that is the ultimate option for time saving in higher...
January 19th, 2012
Trojan Technologies is pleased to announce that further to its news release dated December 27, 2011, Salsnes Filter AS of Namsos, Norway has joined the Trojan Technologies group of businesses. Following the regulatory review period, the acquisition closed on January 19, 2012.“Salsnes delivers a technology that fits well into our municipal business,” says Marv DeVries, president, Trojan...
January 16th, 2012
London, Ontario CANADA – Sumagen Canada Inc. has been awarded a non-refundable financial contribution of up to $728,000 from the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP) to support human clinical trials for our preventative HIV vaccine which is based on a genetically modified killed whole virus, SAV001. Sumagen Canada received approval from the United...
January 9th, 2012
London, Ontario (January 9, 2012): Critical Outcome Technologies Inc. (COTI) (TSX Venture: COT) announced today that the Company will meet with several prospective licensing partners including executives from major pharmaceutical organizations who have expressed interest in its lead oncology drug candidate COTI‐2 at Biotech Showcase. Biotech Showcase is a pharmaceutical partnering...
October 20th, 2011
London, Ontario (October 20, 2011): Critical Outcome Technologies Inc. (COTI) (TSX Venture: COT) announced today the final results of recent pharmacodynamics and pharmacokinetics experiments demonstrating clear evidence of COTI-2's ability to significantly inhibit the growth of cancer cells that over express AKT/AKT2, confirming it as a promising targeted therapy candidate.Detailed...
October 18th, 2011
October 17, 2011 - London, Ontario –Big Blue Bubble Inc. announced today that Burn the Rope Worlds HD has come to the big screen and is now available on the iPad!Burn the Rope Worlds HD follows in the footsteps of the original game with 100 more levels, four different and exciting worlds, and a brand new mini-game called Eternal Burn. In this new game, the player can experience the fun by...
October 13th, 2011
London, Ontario (October 13, 2011): Critical Outcome Technologies Inc. (COTI) (TSX Venture: COT) announced today that a composition of matter patent has been granted by the United States Patent and Trademark Office (USPTO) on October 11, 2011, representing a major milestone for the Company and its most advanced oncology drug candidate, COTI-2.“The granting of this patent by the...
October 13th, 2011
  LONDON, ON, Oct. 13, 2011 /CNW/ - CarProof Vehicle History Reports, a leading information provider delivering up-to-the-minute used vehicle history details to consumers and the automotive industry in Canada, has integrated with Jim Pattison Auto Group (JPAG). Together they provide a used vehicle buying experience that is second to none, and free of the unknown.CarProof reports are...
October 5th, 2011
 LONDON, ONTARIO--(Marketwire - Oct. 5, 2011) - Critical Outcome Technologies Inc. (COTI) (TSX VENTURE:COT) announced today that a scientific abstract about its lead oncology compound, COTI-2, has been accepted for presentation at the upcoming scientific conference, Discovery on Target: Emerging Targets for the Kinase Inhibitor Pipeline. The presentation entitled COTI-2: A highly effective...